Precise technology. Honest quality. Bion Diagnostics, for a healthier tomorrow.

Our History

A legacy built on technology and quality, Bion Diagnostics shapes the future of diagnostics

  1. 2026

    • Export of In Vitro Diagnostic Reagents to Hanoi and Ho Chi Minh City, Vietnam
    • Launch of Clinical Chemistry Analyzers: BC-200 Pro, BC-300 Plus, and BC-400 Elite
    • Successful Periodic GMP Audit for Bion Diagnostics under the Korean Standards for Manufacturing and Quality Control of In Vitro Diagnostic Medical Devices
    • GMP Certification for ALLTEST under the Korean Standards for Manufacturing and Quality Control of In Vitro Diagnostic Medical Devices
    • ISO 13485 Certification Renewal
    • Participation in Vietnam Medi-Pharm 2026 (May 6–9, 2026)
    • Participation in WHX Labs Bangkok 2026 (July 8–10, 2026)
  2. 2025

    • Export of In Vitro Diagnostic Reagents to Uzbekistan
    • Domestic Launch of the DP H-20 Point-of-Care Hematology Analyzer
    • GMP Certification for DYMIND under the Korean Standards for Manufacturing and Quality Control of In Vitro Diagnostic Medical Devices
    • Obtaining a Medical Device Import Business License
    • Obtaining a Veterinary Medical Device Import Business License
    • Registration as a Medical Device Distributor
    • Registration as an E-Commerce Business
    • Establishment of an In-House Corporate Research Institute
    • Trademark Application for “agent POC”
  3. 2024

    • Certified as a Venture Business
    • Obtaining an Import Business License for In Vitro Diagnostic Medical Devices
    • Factory Relocation and Expansion (Uiwang-si, Gyeonggi-do → Incheon Metropolitan City)
    • GMP Certification for LOCMEDT under the Korean Standards for Manufacturing and Quality Control of In Vitro Diagnostic Medical Devices
    • Domestic Launch of the LOC-200 Point-of-Care Clinical Chemistry Analyzer
    • Patent Application: “Multiplexing Diagnostic Apparatus”
    • Patent Application: “Multi-Disk Performing Biochemical Tests, Blood Tests, Immunological Tests, and Genetic Analysis Simultaneously”
  4. 2022

    • Incorporation of Bion Diagnostics Co., Ltd.
  5. 2017

    • Establishment of Bion
    • Obtaining a Manufacturing License for In Vitro Diagnostic Medical Devices
    • Initial GMP Certification for Bion under the Korean Standards for Manufacturing and Quality Control of In Vitro Diagnostic Medical Devices